2-ethyl-2-hydroxy-butyraldehyde | 38562-33-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-ethyl-2-hydroxy-butyraldehyde
• 英文别名: 3-Formyl-pentanol-(3)；2-Aethyl-2-hydroxy-butyraldehyd；2-ethyl-2-hydroxybutanal
• CAS: 38562-33-3
• 化学式: C₆H₁₂O₂
• 分子量: 116.16
• InChiKey: OWJBUOUIJMHBKY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  8
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.83
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  3-dichloromethyl-pentan-3-ol 在 水 、 calcium carbonate 作用下， 生成 2-ethyl-2-hydroxy-butyraldehyde
  参考文献：
  名称：

  Avy, Bulletin de la Societe Chimique de France, 1931, vol. <4> 49, p. 12,17

  摘要：

  DOI：

文献信息

• [EN] MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO<br/>[FR] MODULATEURS POUR LE RÉCEPTEUR MAS COUPLÉ À LA PROTÉINE G ET TRAITEMENT DES TROUBLES QUI Y SONT APPARENTÉS
  申请人：ARENA PHARM INC

  公开号：WO2013070657A1

  公开（公告）日：2013-05-16

  The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts, solvates, and hydrates thereof that are useful in methods of treatment and alleviation of diseases and disorders of the heart, brain, kidney, immune, and reproductive system resulting from ischemia, or reperfusion subsequent to ischemia, and any downstream complication(s) related thereto. The present invention further relates to methods of treatment and alleviation of diseases and disorders of the vasculature resulting from vasoconstriction or hypertension and any downstream complication(s) resulting from elevated blood pressure and/or reduced tissue perfusion.

  本发明涉及式（I）化合物及其药用可接受的盐、溶剂和水合物，这些化合物在治疗和缓解由缺血引起的心脏、脑、肾脏、免疫系统和生殖系统的疾病和紊乱方面具有用处，或者在缺血后再灌注引起的疾病和障碍，以及与之相关的任何下游并发症。本发明还涉及治疗和缓解由血管收缩或高血压引起的血管疾病和障碍的方法，以及由高血压和/或组织灌注减少引起的任何下游并发症。
• 2-aminobenzoxazole derivatives and combinatorial libraries thereof
  申请人：——

  公开号：US20020161028A1

  公开（公告）日：2002-10-31

  The present invention relates to novel 2-aminobenzoxazole derivative compounds of the following formula: 1 wherein R 1 to R 4 and Z have the meanings provided herein. The invention further relates to combinatorial libraries containing two or more such compounds, as well as methods of preparing 2-aminobenzoxazole derivative compounds.

  本发明涉及以下式子的新型2-氨基苯并噁唑衍生物化合物：其中R1至R4和Z具有本文所提供的含义。本发明还涉及包含两种或更多这类化合物的组合式库，以及制备2-氨基苯并噁唑衍生物化合物的方法。
• The use of methoxy(phenyldimethylsilyl)methyl-lithium as a formyl anion equivalent
  作者：David J. Ager、James E. Gano、Shyamal I. Parekh

  DOI：10.1039/c39890001256

  日期：——

  Methoxy(phenyldimethylsilyl)methyl-lithium provides a new formyl anion equivalent which affords α-hydroxyaldehydes via and oxidative desilylation procedure.

  甲氧基（苯基二甲基甲硅烷基）甲基-锂提供了新的甲酰基阴离子当量，该新的甲酰基阴离子通过氧化性甲硅烷基化反应制得α-羟基醛。
• MODULATORS OF THE G PROTEIN-COUPLED MAS RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO
  申请人：ARENA PHARMACEUTICALS, INC.

  公开号：US20140309192A1

  公开（公告）日：2014-10-16

  The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts, solvates, and hydrates thereof: that are useful in methods of treatment and alleviation of diseases and disorders of the heart, brain, kidney, immune, and reproductive system resulting from ischemia, or reperfusion subsequent to ischemia, and any downstream complication(s) related thereto. The present invention further relates to methods of treatment and alleviation of diseases and disorders of the vasculature resulting from vasoconstriction or hypertension and any downstream complication(s) resulting from elevated blood pressure and/or reduced tissue perfusion.

  本发明涉及公式（I）的化合物及其药学上可接受的盐、溶剂合物和水合物，这些化合物对于治疗和缓解由缺血引起的心脏、脑、肾脏、免疫和生殖系统的疾病和障碍以及缺血后再灌注及其相关的任何下游并发症具有用处。本发明还涉及治疗和缓解由血管收缩或高血压引起的血管病变及由升高的血压和/或组织灌注减少引起的任何下游并发症的方法。
• Reactivity of α-Halogenated Aldehydes towards Thiolates: Synthesis of α-Sulfenylated Aldehydes
  作者：R. Verhé、N. De Kimpe、L. De Buyck、N. Schamp

  DOI：10.1055/s-1984-30727

  日期：——